San Francisco-based PharmaCare US Inc. has been hit with a putative class action that alleges the company falsely marketed its product IntenseX as having aphrodisiac properties that increase “sexual power and performance.”

Plaintiff Jonathan Kanfer of West Palm Beach, Florida, claims that no evidence exists to indicate that over-the-counter IntenseX product contains any ingredients that would actually, individually or in combination, provide health or sex-enhancing benefits, according to the complaint filed Jan. 20 in the U.S. District Court for the Southern District of California.